推荐产品
方案
99.9% trace metals basis
表单
powder
反应适用性
reagent type: catalyst
core: thulium
电阻率
90 μΩ-cm, 20°C
粒径
~40 mesh
沸点
1950 °C (lit.)
mp
1545 °C (lit.)
密度
9.332 g/mL at 25 °C (lit.)
SMILES字符串
[Tm]
InChI
1S/Tm
InChI key
FRNOGLGSGLTDKL-UHFFFAOYSA-N
正在寻找类似产品? 访问 产品对比指南
警示用语：
Danger
危险声明
危险分类
Eye Irrit. 2 - Flam. Sol. 1 - STOT SE 3
靶器官
Respiratory system
储存分类代码
4.1B - Flammable solid hazardous materials
WGK
WGK 3
闪点(°F)
Not applicable
闪点(°C)
Not applicable
个人防护装备
dust mask type N95 (US), Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges
Richard L Blackmon et al.
Journal of biomedical optics, 18(2), 28001-28001 (2013-02-05)
Fiber-optic attraction of urinary stones during laser lithotripsy may be exploited to manipulate stone fragments inside the urinary tract without mechanical grasping tools, saving the urologist time and space in the ureteroscope working channel. We compare thulium fiber laser (TFL)
Bo Peng et al.
BJU international, 111(4), 633-637 (2012-10-31)
WHAT'S KNOWN ON THE SUBJECT? AND WHAT DOES THE STUDY ADD?: Thulium laser is a new generation of surgical laser. It is a minimally invasive technology with several advantages, including rapid vaporization and minimal tissue damage and bleeding. However, details
Burcu Tunc et al.
Lasers in surgery and medicine, 45(1), 48-56 (2013-01-17)
The thermal damage of the surrounding tissue can be an unwanted result of continuous-wave laser irradiations. In order to propose an effective alternative to conventional surgical techniques, photothermal damage must be taken under control by a detailed dose study. Real-time
Fabrizio Iacono et al.
BMC surgery, 12 Suppl 1, S21-S21 (2012-11-28)
Over the past years laser technology has played a predominant role in prostate surgery, for the treatment of benign prostate hypertrophy (BPH). Various laser devices have been introduced in clinical practice, showing good results in terms of complications and urodynamic
Zhonghua Yang et al.
Urology, 81(2), 396-400 (2013-02-05)
To compare the clinical outcomes between thulium laser transurethral enucleation of the prostate (ThuLEP) and plasmakinetic bipolar resection of the prostate (PKRP) for treating benign prostatic hyperplasia (BPH) in a prospective randomized trial with 18 months of follow-up. The study
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持